Geron Announces Conference Call to Discuss First Quarter 2016 Financial Results
April 27, 2016 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., April 27, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the first quarter ended March 31, 2016, on Thursday, May 5, 2016,...
Geron Announces Two Imetelstat Poster Presentations at the American Association for Cancer Research Annual Meeting
April 20, 2016 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., April 20, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced two poster presentations of data from non-clinical studies of the telomerase inhibitor,...
Geron to Present at the Needham Healthcare Conference
April 05, 2016 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., April 05, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present...
Geron Corporation Reports Fourth Quarter and Annual 2015 Financial Results
February 25, 2016 16:05 ET
|
Geron Corporation
MENLO PARK, Calif., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the fourth quarter and year ended December 31, 2015 and recent events. ...
Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2015 Financial Results
February 17, 2016 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., Feb. 17, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the fourth quarter and year ended December 31, 2015, on Thursday,...
Geron to Present at the RBC Capital Markets Healthcare Conference
February 10, 2016 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., Feb. 10, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at...
Geron Announces Initiation of Janssen Phase 2/3 Clinical Trial of Imetelstat in Myelodysplastic Syndromes
January 14, 2016 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., Jan. 14, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced the dosing of the first patient in a Phase 2/3 clinical trial to evaluate imetelstat in...
Geron Announces December Conference Presentation Webcasts
November 30, 2015 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., Nov. 30, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present...
Geron to Present At the Stifel Healthcare Conference
November 10, 2015 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., Nov. 10, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at...
Geron Corporation Reports Third Quarter 2015 Financial Results
November 05, 2015 16:05 ET
|
Geron Corporation
MENLO PARK, Calif., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today reported financial results for the third quarter ended September 30, 2015. For the third quarter of...